Cellular immunoresponse in patients with severe drug resistance-falciparum malaria and results of combined treatment of quinin, SMP and thymogen
Journal of Practical Medicine
; : 7-11, 2002.
Article
in Vietnamese
| WPRIM (Western Pacific)
| ID: wpr-1480
Responsible library:
WPRO
ABSTRACT
The study was carried out on 52 patients with severe falciparum malaria 26 cases were treated by quinine, SMP in combination with Thymogene (control group). The results showed that There is a reduction on cellular immune response in severe malaria. Thymogen has contributed to increase the immune response in comparison with this before treatment. Thymogen has contributed shortening time to defervescence, clearance of parasitaemia and coma duration in 2-days after treatment in comparison to control group. Thymogen also has contributed reducing mortality in severe malaria
Full text:
Available
Health context:
SDG3 - Health and Well-Being
/
Neglected Diseases
/
SDG3 - Target 3.3 End transmission of communicable diseases
Health problem:
Target 3.3: End transmission of communicable diseases
/
Malaria
/
Neglected Diseases
/
Antimicrobial Resistance
Database:
WPRIM (Western Pacific)
Main subject:
Therapeutics
/
Drug Resistance
/
Pharmaceutical Preparations
/
Malaria, Falciparum
/
Malaria
Language:
Vietnamese
Journal:
Journal of Practical Medicine
Year:
2002
Document type:
Article
